4//SEC Filing
SAGAN PAUL 4
Accession 0001127602-25-007904
CIK 0001682852other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 4:24 PM ET
Size
7.8 KB
Accession
0001127602-25-007904
Insider Transaction Report
Form 4
Moderna, Inc.MRNA
SAGAN PAUL
Director
Transactions
- Purchase
Common Stock
2025-03-03$31.76/sh+31,620$1,004,251→ 312,027 total(indirect: By Trust)
Holdings
- 166,452(indirect: By Trust)
Common Stock
- 703
Common Stock
- 14,951(indirect: By LLC)
Common Stock
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.46 to $31.95. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- [F2]This balance reflects the transfer of 90,000 shares of the Issuer's common stock from The Paul Sagan Revocable Trust to The Chatham Trust on November 21, 2024.
- [F3]Erwin Park LLC is an investment vehicle owned by the Reporting Person's children. The Chatham Trust is an irrevocable family trust for which the Reporting Person serves as a trustee. The Paul Sagan Revocable Trust is a revocable trust for which the Reporting Person serves as a trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Documents
Issuer
Moderna, Inc.
CIK 0001682852
Entity typeother
Related Parties
1- filerCIK 0001035440
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 4:24 PM ET
- Size
- 7.8 KB